FTC

AbbVie, Allergan merger may face regulatory delay due to COVID-19: report
Fierce Pharma
Tue, 03/17/20 - 11:32 pm
AbbVie
Allergan
FTC
M&A
COVID-19
The FDA and FTC Announce an Effort to Deter Anti-Competitive Practices Among Drugmakers
Motley Fool
Tue, 02/4/20 - 12:01 am
FDA
FTC
drug pricing
anti-competitive scheme
biosimilars
Martin Shkreli is sued by the FTC and NY attorney general for illegally cornering a market
Stat
Mon, 01/27/20 - 11:34 pm
Martin Shkreli
FTC
New York
Vyera Pharmaceuticals
Daraprim
Roche's $4.8B deal for Spark cleared by FTC after long delay
Biopharma Dive
Mon, 12/16/19 - 10:46 pm
Roche
Spark Therapeutics
M&A
FTC
82 Professors Call on Court to Support FTC Decision in Pay-for-Delay Case
RAPS.org
Mon, 12/16/19 - 10:32 pm
FTC
pay-for-delay
Endo Pharmaceuticals
generics
After big M&A year, will pharma move away from massive deals in 2020?
Fierce Pharma
Mon, 12/16/19 - 10:29 pm
M&A
Sanofi
Merck
AbbVie
Allergan
Bristol-Myers Squibb
Celgene
FTC
Disruptor of the Year: The Federal Trade Commission
Biopharma Dive
Mon, 12/9/19 - 11:16 pm
FTC
M&A
Roche
Spark Therapeutics
Bristol-Celgene Merger Leaps FTC Clearance; Deal Set To Close Wednesday
Investors Business Daily
Sat, 11/16/19 - 10:30 pm
Bristol-Myers Squibb
Celgene
FTC
M&A
FTC requests AbbVie, Allergan for more information on $63 billion deal
Reuters
Sat, 09/28/19 - 04:31 pm
FTC
M&A
AbbVie
Allergan
U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers
Reuters
Wed, 09/18/19 - 11:24 am
Senate
FTC
M&A
[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
Motley Fool
Sat, 09/7/19 - 06:16 pm
FTC
Amgen
Celgene
Bristol-Myers Squibb
M&A
Otezla
Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?
Endpoints
Tue, 09/3/19 - 10:56 am
Roche
Spark Therapeutics
FTC
CMA
M&A
Six burning Otezla questions
EP Vantage
Tue, 08/27/19 - 10:53 pm
Celgene
Otezla
Amgen
drug pricing
FTC
Tyk2
Bristol-Myers Squibb
FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade
Endpoints
Tue, 07/30/19 - 07:59 am
FTC
JNJ
Remicade
antitrust
biosimilars
Pfizer
Inflectra
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases
CP Wire
Mon, 07/22/19 - 07:39 pm
whistleblower lawsuits
Reckitt Benckiser
FTC
opioids
opioid addiction
Suboxone
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases
Mon, 07/22/19 - 05:19 pm
whistleblower lawsuits
Reckitt Benckiser
FTC
opioids
opioid addiction
Suboxone
In surprise switch, Bristol-Myers is selling off blockbuster Otezla, promising to complete Celgene acquisition — just later
Endpoints
Mon, 06/24/19 - 11:23 am
Bristol-Myers Squibb
Opdivo
Otezla
M&A
FTC
Celgene
FTC demands could mean months-long delay for Roche-Spark deal
Biopharma Dive
Wed, 06/12/19 - 06:44 pm
Roche
Spark Therapeutics
FTC
M&A
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Endpoints
Mon, 06/10/19 - 07:38 pm
Spark Therapeutics
Roche
FTC
UK
M&A
Judge, CVS witness clash on merger settlement, July hearing set
Biopharma Dive
Fri, 06/7/19 - 09:55 pm
M&A
CVS Health
Aetna
FTC

Pages